JP2886127B2 - 水溶性シクロデキストリン誘導体の浄化方法 - Google Patents
水溶性シクロデキストリン誘導体の浄化方法Info
- Publication number
- JP2886127B2 JP2886127B2 JP8026674A JP2667496A JP2886127B2 JP 2886127 B2 JP2886127 B2 JP 2886127B2 JP 8026674 A JP8026674 A JP 8026674A JP 2667496 A JP2667496 A JP 2667496A JP 2886127 B2 JP2886127 B2 JP 2886127B2
- Authority
- JP
- Japan
- Prior art keywords
- cyclodextrin
- membrane
- water
- reverse osmosis
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title claims description 32
- 238000000746 purification Methods 0.000 title claims description 24
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical class O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 title claims description 19
- 239000012528 membrane Substances 0.000 claims description 47
- 238000001223 reverse osmosis Methods 0.000 claims description 35
- 238000000926 separation method Methods 0.000 claims description 15
- 150000003839 salts Chemical class 0.000 description 32
- 239000000243 solution Substances 0.000 description 31
- 229920000858 Cyclodextrin Polymers 0.000 description 24
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 17
- 239000000047 product Substances 0.000 description 16
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 15
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 15
- 239000008186 active pharmaceutical agent Substances 0.000 description 15
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 14
- 239000000203 mixture Substances 0.000 description 14
- 239000012466 permeate Substances 0.000 description 14
- 238000001914 filtration Methods 0.000 description 13
- 238000009472 formulation Methods 0.000 description 13
- 239000012465 retentate Substances 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 239000011780 sodium chloride Substances 0.000 description 12
- 102220588656 Chromatin target of PRMT1 protein_R76A_mutation Human genes 0.000 description 10
- 239000001116 FEMA 4028 Substances 0.000 description 10
- 229960004853 betadex Drugs 0.000 description 10
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 description 10
- 238000000108 ultra-filtration Methods 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 239000000706 filtrate Substances 0.000 description 9
- 238000004448 titration Methods 0.000 description 9
- YZOUYRAONFXZSI-SBHWVFSVSA-N (1S,3R,5R,6R,8R,10R,11R,13R,15R,16R,18R,20R,21R,23R,25R,26R,28R,30R,31S,33R,35R,36R,37S,38R,39S,40R,41S,42R,43S,44R,45S,46R,47S,48R,49S)-5,10,15,20,25,30,35-heptakis(hydroxymethyl)-37,39,40,41,42,43,44,45,46,47,48,49-dodecamethoxy-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontane-36,38-diol Chemical compound O([C@@H]([C@H]([C@@H]1OC)OC)O[C@H]2[C@@H](O)[C@@H]([C@@H](O[C@@H]3[C@@H](CO)O[C@@H]([C@H]([C@@H]3O)OC)O[C@@H]3[C@@H](CO)O[C@@H]([C@H]([C@@H]3OC)OC)O[C@@H]3[C@@H](CO)O[C@@H]([C@H]([C@@H]3OC)OC)O[C@@H]3[C@@H](CO)O[C@@H]([C@H]([C@@H]3OC)OC)O3)O[C@@H]2CO)OC)[C@H](CO)[C@H]1O[C@@H]1[C@@H](OC)[C@H](OC)[C@H]3[C@@H](CO)O1 YZOUYRAONFXZSI-SBHWVFSVSA-N 0.000 description 8
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 8
- 239000004952 Polyamide Substances 0.000 description 7
- 229920002647 polyamide Polymers 0.000 description 7
- CUJVBAPGYBSBHJ-YWBSARSQSA-N 2-[[(1R,3R,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21R,23R,25R,26R,28R,30R,31R,33R,35R,36R,37R,38R,39R,40R,41R,42R,43R,44R,45R,46R,47R,48R,49R)-36,38,40,42-tetrakis(carboxymethoxy)-10,15-bis(carboxymethoxymethyl)-37,39,41,43,44,45,46,47,48,49-decahydroxy-20,25,30,35-tetrakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontan-5-yl]methoxy]acetic acid Chemical compound OC[C@H]1O[C@@H]2O[C@H]3[C@H](O)[C@@H](O)[C@H](O[C@@H]3COCC(O)=O)O[C@H]3[C@H](O)[C@@H](O)[C@H](O[C@@H]3COCC(O)=O)O[C@H]3[C@H](O)[C@@H](O)[C@H](O[C@@H]3COCC(O)=O)O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@H]1[C@H](OCC(O)=O)[C@H]2O)[C@H](O)[C@H]5OCC(O)=O)[C@H](O)[C@H]4OCC(O)=O)[C@H](O)[C@H]3OCC(O)=O CUJVBAPGYBSBHJ-YWBSARSQSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 6
- 238000005160 1H NMR spectroscopy Methods 0.000 description 4
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 239000002904 solvent Chemical group 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 102220605057 Histone H4-like protein type G_R75A_mutation Human genes 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000003125 aqueous solvent Substances 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 3
- -1 hydroxypropyl Chemical group 0.000 description 3
- 238000004255 ion exchange chromatography Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 238000001694 spray drying Methods 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 229940097362 cyclodextrins Drugs 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 229940080345 gamma-cyclodextrin Drugs 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- NZAQRZWBQUIBSF-UHFFFAOYSA-N 4-(4-sulfobutoxy)butane-1-sulfonic acid Chemical compound OS(=O)(=O)CCCCOCCCCS(O)(=O)=O NZAQRZWBQUIBSF-UHFFFAOYSA-N 0.000 description 1
- YDHNHFNGJCKAIZ-UHFFFAOYSA-N 6-chloro-1,3,5-triazine-2,4-diol Chemical compound OC1=NC(O)=NC(Cl)=N1 YDHNHFNGJCKAIZ-UHFFFAOYSA-N 0.000 description 1
- 101100459438 Caenorhabditis elegans nac-1 gene Proteins 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 1
- DUFKCOQISQKSAV-UHFFFAOYSA-N Polypropylene glycol (m w 1,200-3,000) Chemical compound CC(O)COC(C)CO DUFKCOQISQKSAV-UHFFFAOYSA-N 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000009295 crossflow filtration Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- LRQFRDLKOBFOSG-UHFFFAOYSA-N trimethyl(oxiran-2-ylmethyl)azanium Chemical compound C[N+](C)(C)CC1CO1 LRQFRDLKOBFOSG-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19505263A DE19505263A1 (de) | 1995-02-16 | 1995-02-16 | Verfahren zur Reinigung von wasserlöslichen Cyclodextrinderivaten |
| DE19505263.3 | 1995-02-16 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH08259605A JPH08259605A (ja) | 1996-10-08 |
| JP2886127B2 true JP2886127B2 (ja) | 1999-04-26 |
Family
ID=7754169
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP8026674A Expired - Lifetime JP2886127B2 (ja) | 1995-02-16 | 1996-02-14 | 水溶性シクロデキストリン誘導体の浄化方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US5831081A (cg-RX-API-DMAC10.html) |
| EP (1) | EP0727440B2 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2886127B2 (cg-RX-API-DMAC10.html) |
| DE (2) | DE19505263A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19605683A1 (de) * | 1996-02-16 | 1997-09-11 | Forschungszentrum Juelich Gmbh | Verfahren zur Trennung von Substanzen mittels einer geeigneten Membran |
| ATE348116T1 (de) * | 1999-11-12 | 2007-01-15 | Freres Roquette | Kristalline mischungen aus teilmethylestern des beta-cyclodextrins und verwandten verbindungen |
| US6527887B1 (en) | 2002-01-18 | 2003-03-04 | Mach I, Inc. | Polymeric cyclodextrin nitrate esters |
| MX2008006090A (es) | 2005-11-09 | 2008-10-23 | Proteolix Inc | Compuestos para inhibicion de la enzima. |
| RU2450016C2 (ru) | 2006-06-19 | 2012-05-10 | Протеоликс, Инк. | Пептидные эпоксикетоны для ингибирования протеасомы |
| KR20160086980A (ko) | 2007-10-04 | 2016-07-20 | 오닉스 세라퓨틱스, 인크. | 결정형 펩티드 에폭시 케톤 프로테아제 저해제 및 아미노산 케토-에폭시드의 합성 |
| US7635773B2 (en) | 2008-04-28 | 2009-12-22 | Cydex Pharmaceuticals, Inc. | Sulfoalkyl ether cyclodextrin compositions |
| MX2011004225A (es) | 2008-10-21 | 2011-06-21 | Onyx Therapeutics Inc | Terapia de combinacion con epoxicetonas peptidicas. |
| AR075899A1 (es) | 2009-03-20 | 2011-05-04 | Onyx Therapeutics Inc | Tripeptidos epoxicetonas cristalinos inhibidores de proteasa |
| WO2011060179A1 (en) | 2009-11-13 | 2011-05-19 | Onyx Therapeutics, Inc | Use of peptide epoxyketones for metastasis suppression |
| BR112012022060A2 (pt) | 2010-03-01 | 2018-05-08 | Onyx Therapeutics Inc | composto para a inibição de imunoproteassoma |
| EP2555621A4 (en) | 2010-04-07 | 2014-07-02 | Onyx Therapeutics Inc | CRYSTALLINE EPOXYCETONE PEPTIDE IMMUNOPROTEASOME INHIBITOR |
| PT3702374T (pt) | 2012-02-15 | 2022-06-23 | Cydex Pharmaceuticals Inc | Processo de fabrico para derivados de ciclodextrina |
| CA2865950C (en) * | 2012-02-28 | 2016-12-20 | Cydex Pharmaceuticals, Inc. | Alkylated cyclodextrin compositions and processes for preparing and using the same |
| SMT202400264T1 (it) * | 2012-05-08 | 2024-07-09 | Onyx Therapeutics Inc | Metodi di complessazione di ciclodestrina per formulare inibitori del proteasoma peptidico |
| WO2014011695A2 (en) | 2012-07-09 | 2014-01-16 | Onyx Therapeutics, Inc. | Prodrugs of peptide epoxy ketone protease inhibitors |
| HK1213585A1 (zh) | 2012-10-22 | 2016-07-08 | Cydex Pharmaceuticals, Inc. | 烷基化环糊精组合物及其制备和使用方法 |
| FI3183295T3 (fi) | 2014-08-22 | 2023-09-25 | Cydex Pharmaceuticals Inc | Fraktioidut alkyloidut syklodekstriinikoostumukset ja menetelmät niiden valmistamiseksi ja käyttämiseksi |
| EP3814386A1 (fr) * | 2018-06-29 | 2021-05-05 | Roquette Freres | NOUVELLE HYDROXYPROPYL-ß-CYCLODEXTRINE ET SON PROCÉDÉ DE PRÉPARATION |
| CN112142875A (zh) * | 2019-06-27 | 2020-12-29 | 广东东阳光药业有限公司 | 一种舒更葡糖钠的精制方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3453257A (en) * | 1967-02-13 | 1969-07-01 | Corn Products Co | Cyclodextrin with cationic properties |
| DE2357731A1 (de) * | 1973-11-20 | 1975-05-22 | Merck Patent Gmbh | Verfahren zum austausch von ionischen bestandteilen organischer verbindungen |
| DE2700011A1 (de) * | 1977-01-03 | 1978-07-06 | Hideo Omoto | Hydroxyaethylstaerke, verfahren zu ihrer herstellung und sie enthaltender plasmaersatz |
| JPS6013678B2 (ja) * | 1981-06-08 | 1985-04-09 | 農林水産省食品総合研究所長 | サイクロデキストリンの製造方法 |
| US4870060A (en) * | 1985-03-15 | 1989-09-26 | Janssen Pharmaceutica | Derivatives of γ-cylodextrin |
| JPS62104590A (ja) * | 1985-11-01 | 1987-05-15 | Ensuikou Seito Kk | サイクロデキストリンの製造法 |
| JPS6327440A (ja) † | 1986-07-18 | 1988-02-05 | Sanraku Inc | グルコシル化分岐シクロデキストリン含有組成物 |
| JPS63229109A (ja) * | 1987-03-17 | 1988-09-26 | Asahi Chem Ind Co Ltd | スルホン化ポリフエニレンオキサイド複合半透膜の製造方法 |
| HK1009335A1 (en) * | 1989-04-03 | 1999-05-28 | Janssen Pharmaceutica N.V. | Regioselective substitutions in cyclodextrins |
| KR0166088B1 (ko) * | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
| JP2905573B2 (ja) * | 1990-06-28 | 1999-06-14 | 日本食品化工株式会社 | ヒドロキシアルキル化シクロデキストリン精製物及びその製造法 |
| US5041227A (en) * | 1990-10-09 | 1991-08-20 | Bend Research, Inc. | Selective aqueous extraction of organics coupled with trapping by membrane separation |
| FR2668163B1 (fr) * | 1990-10-18 | 1993-01-15 | Orsan | Procede de fabrication de beta-cyclodextrine. |
| US5221485A (en) † | 1991-12-03 | 1993-06-22 | Mallinckrodt Medical, Inc. | Purification of X-ray contrast agent, magnetic resonance imaging agent, or radiopharmaceuticals using reverse osmosis |
-
1995
- 1995-02-16 DE DE19505263A patent/DE19505263A1/de not_active Ceased
- 1995-05-31 US US08/454,940 patent/US5831081A/en not_active Expired - Lifetime
-
1996
- 1996-02-14 JP JP8026674A patent/JP2886127B2/ja not_active Expired - Lifetime
- 1996-02-15 EP EP96102245A patent/EP0727440B2/de not_active Expired - Lifetime
- 1996-02-15 DE DE59605527T patent/DE59605527D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US5831081A (en) | 1998-11-03 |
| EP0727440A2 (de) | 1996-08-21 |
| EP0727440A3 (cg-RX-API-DMAC10.html) | 1996-08-28 |
| DE59605527D1 (de) | 2000-08-10 |
| EP0727440B2 (de) | 2003-11-26 |
| EP0727440B1 (de) | 2000-07-05 |
| JPH08259605A (ja) | 1996-10-08 |
| DE19505263A1 (de) | 1996-08-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2886127B2 (ja) | 水溶性シクロデキストリン誘導体の浄化方法 | |
| EP0632056B1 (en) | Purification of aqueous reaction or washing medium containing cellulose ethers | |
| US6933381B2 (en) | Method of preparing modified cellulose ether | |
| PT832108E (pt) | Processo para recuperacao de compostos insoluveis em agua a partir de um caldo de fermentacao | |
| KR19980067429A (ko) | 이눌린 생성물의 제조법 | |
| JPS624702A (ja) | 水溶性アシル化キトサンの製造方法 | |
| US5218107A (en) | Removal of undesirable material from water-soluble cellulose ether aqueous solutions | |
| JPH0649721B2 (ja) | セルロース、アルカリ金属水酸化物及びエーテル化剤少なくとも１種からセルロースエーテルを製造する際に得られる液状反応及び／又は洗浄媒体を浄化処理する方法 | |
| EP0545426B1 (de) | Verfahren zur reinigenden Aufbereitung von bei der Herstellung von Celluloseethern anfallenden Reaktions- und/oder Waschmedien | |
| BG63086B1 (bg) | Метод за изолиране на клавуланова киселина от ферментационна хранителна среда чрез ултрафилтруване | |
| CA1155112A (en) | Process for the purification of glucosaminoglucans | |
| JPH0734750B2 (ja) | エリスリトールの分離・回収方法 | |
| EP1236741B1 (en) | Process for recovering cellulose ethers from aqueous solutions via enhanced shear ultrafiltration | |
| CA2241193A1 (en) | Process for purifying a liquid contaminated by filamentary molecules | |
| CN1303853A (zh) | 浓缩儿茶素溶液的方法 | |
| JP2001190933A5 (cg-RX-API-DMAC10.html) | ||
| EP4414360A1 (en) | Method for purification of amino acid surfactants | |
| JPH07133289A (ja) | 蛋白質分離精製方法 | |
| KR101744134B1 (ko) | 나노 여과 공정을 포함한 l-핵산 유도체의 제조 방법 | |
| AU5464399A (en) | Production of polysaccharide ethers | |
| JPH04284828A (ja) | 膜分離方法 | |
| KR20170116678A (ko) | 아스코르브산 배당체의 정제 방법 | |
| JPH07330789A (ja) | 硫酸化糖の精製方法 | |
| CN1500812A (zh) | 一种高分子量的水溶性甲壳素衍生物的提纯方法 | |
| MXPA01001247A (en) | Production of polysaccharide ethers |